Foodborne Salmonella-Caused Outbreaks in Catalonia (Spain), 1990 to 2003
Ángela Domı́nguez(Instituto de Salud Carlos III), Antoni Plasència(Barcelona Institute for Global Health), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Àngel Teixidó(Generalitat de Catalunya), Laura Ruíz(Generalitat de Catalunya), Elena Sulleiro(Instituto de Salud Carlos III), Rosa Bartolomé(Universitat Autònoma de Barcelona), Núria Torner(Centro de Investigación Biomédica en Red)
Cited by 27
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334